Search

Search Constraints

You searched for: Author/Creator Fortea, Juan

Search Results

1. 1H‐MRS signature in Alzheimer disease in Down syndrome: Neuroimaging / Optimal neuroimaging measures for tracking disease progression. (7th December 2020)

2. [O1–06–02]: BIPHASIC MODEL IN PRECLINICAL ALZHEIMER's DISEASE: AV45 PET, CSF TAU AND CORTICAL THICKNESS. (1st July 2017)

3. [O3–10–03]: LONGITUDINAL CEREBROSPINAL FLUID BIOMARKER TRAJECTORIES ALONG THE ALZHEIMER'S DISEASE CONTINUUM: A MULTICENTRE EUROPEAN STUDY. (1st July 2017)

4. [P1–238]: THE SAPPβ/YKL‐40 RATIO IN CEREBROSPINAL FLUID AS A DIAGNOSTIC MARKER IN FRONTOTEMPORAL LOBAR DEGENERATION: A PATHOLOGICAL STUDY. (1st July 2017)

5. [P1–366]: WEIGHT LOSS MIGHT BE A NON‐COGNITIVE SIGN OF PRECLINICAL ALZHEIMER'S DISEASE. (1st July 2017)

6. [P2–259]: NETWORK ANALYSIS OF THE CSF PROTEOME IDENTIFIES SYNAPTIC PROTEINS OF HIPPOCAMPAL ORIGIN AS PUTATIVE BIOMARKERS FOR AD‐RELATED SYNAPSE LOSS. (1st July 2017)

7. [P3–274]: STRUCTURAL CORRELATES OF ALZHEIMER's DISEASE AND AGING IN DOWN SYNDROME: AN MRI STUDY. (1st July 2017)

8. [P4–505]: CORTICAL MICROSTRUCTURAL CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION: A NEW IMAGING BIOMARKER. (1st July 2017)

9. A multimodal study on the effect of sex on Alzheimer's disease clinical and biomarker changes in adults with Down syndrome. (31st December 2021)

10. Accelerated long‐term forgetting in individuals with subjective cognitive decline and amyloid‐β positivity. (15th April 2021)